z-logo
open-access-imgOpen Access
Anticoagulation and Survival in Pulmonary Arterial Hypertension
Author(s) -
Karen M. Olsson,
Marion Delcroix,
Hossein A. Ghofrani,
Henning Tiede,
Dörte Huscher,
Rudolf Speich,
Ekkehard Grünig,
Gerd Staehler,
Stephan Rosenkranz,
Michael Halank,
Matthias Held,
Tobias Lange,
Jürgen Behr,
Hans Klose,
Martin Claussen,
Ralf Ewert,
Christian Opitz,
Carmine Dario Vizza,
Laura Scelsi,
Anton Vonk Noordegraaf,
Harald Kaemmerer,
J. Simon R. Gibbs,
Gerry Coghlan,
Joanna PepkeŻaba,
Uwe Schulz,
Matthias Gorenflo,
David Pittrow,
Marius M. Hoeper
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.004526
Subject(s) - medicine , pulmonary hypertension , cardiology , intensive care medicine
For almost 30 years, anticoagulation has been recommended for patients with idiopathic pulmonary arterial hypertension (IPAH). Supporting evidence, however, is limited, and it is unclear whether this recommendation is still justified in the modern management era and whether it should be extended to patients with other forms of pulmonary arterial hypertension (PAH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom